Literature DB >> 12169207

Apoptosis in the immune system: 1. Fas-induced apoptosis in monocytes-derived human dendritic cells.

Roxana Nat1, E Radu, T Regalia, L M Popescu.   

Abstract

Dendritic cells (DC) are cells of the hematopoietic system specialized in capturing antigens and initiating T cell-mediated immune responses. We show here that human DC generated from adherent peripheral blood mononuclear cells (PBMC) after in vitro stimulation with granulocyte macrophage colony stimulating factor (GM-CSF) and interleukin-4 (IL-4) express Fas antigen (APO-1, CD95) and can undergo apoptosis upon triggering of Fas by monoclonal antibodies. Immature monocytes-derived dendritic cells (MDDC) upregulate CD86 and HLA-DR expression and develop dendrites and veiled processes. Flow cytometry analysis revealed CD95 expression in approx. 40% of these MDDC and incubation with anti-CD95 mAb (0.5 microg/ml) induced apoptosis when compared to untreated controls. The extent of apoptosis induced by the agonist anti-Fas antibody strongly related to the percentage of cells expressing CD 95. Upon tumor necrosis factor alpha (TNF-alpha) additional stimulation, MDDC assumed a characteristic mature dendritic cells morphology showing prolonged veils, CD83 expression, and high levels of HLA-DR. These cells have downregulated their Fas receptors (to approx. 20%) and undergo apoptosis to a lesser extent when treated with anti-CD 95, as demonstrated by the hardly noticeable effect of this antibody on the viability of cultured cells as compared to controls. Thus, upon TNF-alpha induced maturation, MDDC became resistant to Fas-induced apoptosis. The apoptotic episodes surrounding the earlier stage of DC differentiation appeared to be mediated by Fas. In contrast, a Fas independent pathway is probably responsible for the apoptotic events associated with terminally differentiated DC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169207      PMCID: PMC6740210          DOI: 10.1111/j.1582-4934.2002.tb00189.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  5 in total

1.  MHC class II vesicles (CIIV) within immature dendritic cells.

Authors:  E Radu; T Regalia
Journal:  J Cell Mol Med       Date:  2004 Apr-Jun       Impact factor: 5.310

Review 2.  Transcription factors in the control of dendritic cell life cycle.

Authors:  Arpita S Bharadwaj; Devendra K Agrawal
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Lipopolysaccharide-induced expression of TRAIL promotes dendritic cell differentiation.

Authors:  Young S Cho; Sreerupa Challa; Lauren Clancy; Francis K-M Chan
Journal:  Immunology       Date:  2010-04-06       Impact factor: 7.397

4.  A simian virus 5 (SV5) P/V mutant is less cytopathic than wild-type SV5 in human dendritic cells and is a more effective activator of dendritic cell maturation and function.

Authors:  Subhashini Arimilli; Martha A Alexander-Miller; Griffith D Parks
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

5.  Oral bacteria induce a differential activation of human immunodeficiency virus-1 promoter in T cells, macrophages and dendritic cells.

Authors:  C B Huang; K A Emerson; O A Gonzalez; J L Ebersole
Journal:  Oral Microbiol Immunol       Date:  2009-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.